BR112019010785A8 - Processo para produzir uma forma de dosagem revestida - Google Patents

Processo para produzir uma forma de dosagem revestida

Info

Publication number
BR112019010785A8
BR112019010785A8 BR112019010785A BR112019010785A BR112019010785A8 BR 112019010785 A8 BR112019010785 A8 BR 112019010785A8 BR 112019010785 A BR112019010785 A BR 112019010785A BR 112019010785 A BR112019010785 A BR 112019010785A BR 112019010785 A8 BR112019010785 A8 BR 112019010785A8
Authority
BR
Brazil
Prior art keywords
dosage form
producing
activator
period
active ingredient
Prior art date
Application number
BR112019010785A
Other languages
English (en)
Other versions
BR112019010785A2 (pt
Inventor
P Mcnally Gerard
Anderson Oliver
Koll Greg
Szymzcak Christopher
Pandey Anurag
Original Assignee
Currahee Holding Company Inc
Johnson & Johnson Consumer Inc
Chenango Zero Llc
Chenango Two Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Currahee Holding Company Inc, Johnson & Johnson Consumer Inc, Chenango Zero Llc, Chenango Two Llc filed Critical Currahee Holding Company Inc
Publication of BR112019010785A2 publication Critical patent/BR112019010785A2/pt
Publication of BR112019010785A8 publication Critical patent/BR112019010785A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A presente invenção refere-se a um processo para produzir uma forma de dosagem que compreende ao menos um ingrediente farmaceuticamente ativo, em que o método compreende as etapas de (i) fornecer um formato da forma de dosagem que compreende pelo menos duas camadas de pó, em que a primeira camada de pó compreende um agente estabilizante de superfície e a segunda camada de pó compreende ao menos um ativador e o ingrediente farmaceuticamente ativo, em que o ativador tem um valor Q menor que 75; (ii) aplicar uma energia de radiofrequência por um período de tempo suficiente ao formato da etapa (i); e (iii) aplicar calor por um período de tempo suficiente ao formato da etapa (i).
BR112019010785A 2016-11-28 2017-11-27 Processo para produzir uma forma de dosagem revestida BR112019010785A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662426754P 2016-11-28 2016-11-28
PCT/US2017/063282 WO2018098434A1 (en) 2016-11-28 2017-11-27 Process for making a coated dosage form

Publications (2)

Publication Number Publication Date
BR112019010785A2 BR112019010785A2 (pt) 2019-10-01
BR112019010785A8 true BR112019010785A8 (pt) 2022-08-09

Family

ID=60570278

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019010785A BR112019010785A8 (pt) 2016-11-28 2017-11-27 Processo para produzir uma forma de dosagem revestida

Country Status (8)

Country Link
US (1) US20180147153A1 (pt)
EP (1) EP3544585A1 (pt)
CN (1) CN110225745A (pt)
AU (1) AU2017363357B2 (pt)
BR (1) BR112019010785A8 (pt)
CA (1) CA3044867A1 (pt)
RU (1) RU2771159C2 (pt)
WO (1) WO2018098434A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019109633A (ru) * 2016-09-09 2020-10-09 Мерк Патент Гмбх Способ изготовления твердой фармацевтической лекарственной формы
US20200276087A1 (en) * 2017-09-21 2020-09-03 Hoffmann-La Roche Inc. Pharmaceutical manufacturing installation and method of manufacturing of a pharmaceutical product

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851226A (en) 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4906478A (en) 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5223264A (en) 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5275822A (en) 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
US5075114A (en) 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2068402C (en) 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
ATE213154T1 (de) 1996-06-17 2002-02-15 Janssen Pharmaceutica Nv Bikonvexe, rasch desintegrierende verabreichungsformen
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6589554B1 (en) 1998-03-16 2003-07-08 Yamanouchi Pharmaceutical Co., Ltd. Tablets quickly disintegrating in the oral cavity and process for producing the same
US20090104273A1 (en) * 1999-06-22 2009-04-23 Elan Pharma International Ltd. Novel nifedipine compositions
US6767200B2 (en) 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
TW200526221A (en) * 2003-09-02 2005-08-16 Imran Ahmed Sustained release dosage forms of ziprasidone
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8871263B2 (en) * 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
CN102762198A (zh) * 2010-05-15 2012-10-31 欢腾生命科学有限公司 多单元组合物
US20110319492A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Manufacture of tablets from energy-applied powder blend
WO2012039790A1 (en) * 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Manufacture of tablets from energy-applied powder blend
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) * 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US20130295174A1 (en) * 2012-05-01 2013-11-07 Mcneil-Ppc, Inc. Tablet comprising a first and second region
WO2015105992A1 (en) * 2014-01-10 2015-07-16 Mcneil-Ppc, Inc. Process for making tablet using radiofrequency and lossy coated particles

Also Published As

Publication number Publication date
CA3044867A1 (en) 2018-05-31
CN110225745A (zh) 2019-09-10
RU2019119845A (ru) 2020-12-28
AU2017363357A1 (en) 2019-06-13
AU2017363357B2 (en) 2023-10-05
BR112019010785A2 (pt) 2019-10-01
US20180147153A1 (en) 2018-05-31
WO2018098434A1 (en) 2018-05-31
EP3544585A1 (en) 2019-10-02
RU2771159C2 (ru) 2022-04-27
RU2019119845A3 (pt) 2020-12-28

Similar Documents

Publication Publication Date Title
CL2020000926A1 (es) Composiciones para la liberación controlada de ingredientes activos y método para hacer las mismas. (divisional solicitud 201802371)
BR112016015944A8 (pt) processo para produzir comprimido, que usa radiofrequência e partículas revestidas dissipadoras de energia
BR112014015104A2 (pt) método para expandir o diâmetro de um recipiente de metal
BR112016014146A2 (pt) Métodos para formatar material fibroso e composições de tratamento para os mesmos
BR112017019582A2 (pt) espuma de pele integral, sola de sapato, artigo de fabricação, e método para fazer espuma de pele integral
EP3257964A4 (en) Manufacturing method for deposition mask, metal sheet used for producing deposition mask, and manufacturing method for said metal sheet
MX2018015255A (es) Metodos para fabricar aplicadores de precision.
EP3410215A4 (en) FILM MASK, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR FORMING A PATTERN WITH THE FILM MASK AND PATTERN MADE THEREFOR
BR112019010785A8 (pt) Processo para produzir uma forma de dosagem revestida
AR107327A1 (es) Productos alimenticios revestidos
EP3410214A4 (en) FILM MASK, METHOD OF MANUFACTURING THE SAME, AND METHOD FOR FORMING PATTERNS USING THE FILM MASK, AND PATTERN THUS FORMED
EP3713537A4 (en) TOPICAL COMPOSITIONS, THEIR MANUFACTURING PROCESS AND THEIR USE OF
EP3515699A4 (en) EMBOSSING TAPE, METHOD FOR THE PRODUCTION THEREOF AND ITEM THEREFOR
PH12016502536A1 (en) Composite preparation comprising 5-a-reductase inhibitor-containing film coating layer, and method for producing the composite preparation
BR112017015686A2 (pt) processo para preparo de microcápsulas sem melamina-formaldeído
CO2020008586A2 (es) Tripa alimentaria con propiedades antifúngicas y método para la producción de la misma
BR112018012043A2 (pt) processo para a redução da transpiração
BR112021020514A2 (pt) Isolamento térmico
EP3859029A4 (en) METAL MASK MATERIAL, ITS PRODUCTION METHOD AND METAL MASK
EP3842491A4 (en) COMPOUND, COMPOSITION THEREOF, METHOD FOR PRODUCING A RESIST PATTERN AND METHOD FOR PRODUCING AN INSULATING FILM
PH12018501277A1 (en) Corticosteroid containing foam compositions and method of manufacture thereof
MX2018004905A (es) Composición para formar película de aislamiento de lámina de acero eléctrico orientado, método para formar película de aislamiento usando la misma, y lámina de acero eléctrico orientado que tiene película de aislamiento formada en la misma.
BR112017025739A2 (pt) composição farmacêutica oral de isotretinoína que tem biodisponibilidade aumentada, processo para preparar a mesma e método de tratamento
AR106221A1 (es) Una composición de toxicidad baja
WO2012127495A3 (en) Pharmaceutical composition and process for preparation thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25G Requested change of headquarter approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.7 NA RPI NO 2773 DE 27/02/2024 POR TER SIDO INDEVIDA.

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.4 NA RPI NO 2786 DE 28/05/2024 POR TER SIDO INDEVIDA.